Corticosteroids as adjuvant therapy for ocular toxoplasmosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Corticosteroids as Adjuvant Therapy for Ocular Toxoplasmosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435892/all/Mirtazapine_versus_other_antidepressive_agents_for_depression:_Cochrane_systematic_review. Accessed 04 December 2023.
Corticosteroids as adjuvant therapy for ocular toxoplasmosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435892/all/Mirtazapine_versus_other_antidepressive_agents_for_depression:_Cochrane_systematic_review. Accessed December 4, 2023.
Corticosteroids as adjuvant therapy for ocular toxoplasmosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435892/all/Mirtazapine_versus_other_antidepressive_agents_for_depression:_Cochrane_systematic_review
Corticosteroids as Adjuvant Therapy for Ocular Toxoplasmosis [Internet]. In: Cochrane Abstracts. [cited 2023 December 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435892/all/Mirtazapine_versus_other_antidepressive_agents_for_depression:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Corticosteroids as adjuvant therapy for ocular toxoplasmosis
ID - 435892
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435892/all/Mirtazapine_versus_other_antidepressive_agents_for_depression:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -